G. H. Evans

发表

Disposition of propranolol V. Drug accumulation and steady‐state concentrations during chronic oral administration in man

D. Shand, G. H. Evans, Gwyn H. Evans, 1973, Clinical pharmacology and therapeutics.

The Disposition of Propranolol

D. Shand, R. Rangno, G. H. Evans, 1972 .

The effect of chromium picolinate on insulin controlled parameters in humans

G. H. Evans, G. Evans, 1989 .

Dietary magnesium does not affect blood pressure in spontaneously hypertensive rats.

C. Babbs, C. Weaver, D. Harrington, 1989, Clinical and experimental hypertension. Part A, Theory and practice.

Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate.

D. Shand, A. Nies, G. H. Evans, 1973, American heart journal.

The almost complete hepatic extraction of propranolol during intravenous administration in the dog.

D. Shand, A. Nies, G. H. Evans, 1971, Life sciences. Pt. 1: Physiology and pharmacology.

The disposition of propranolol. IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver.

G. Wilkinson, D. Shand, G. H. Evans, 1973, The Journal of pharmacology and experimental therapeutics.

The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol.

D. Shand, A. Nies, G. H. Evans, 1973, The Journal of pharmacology and experimental therapeutics.

The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.

D. Shand, A. Nies, G. H. Evans, 1973, The Journal of pharmacology and experimental therapeutics.

The disposition of propranolol. VII. The effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver.

R. Branch, G. Wilkinson, D. Shand, 1973, Drug metabolism and disposition: the biological fate of chemicals.

The disposition of propranolol. II. Hepatic elimination in the rat.

D. Shand, R. Rangno, G. H. Evans, 1972, Pharmacology.